NIAID Funding News, June 20, 2024

June 20, 2024 NIAID Funding News Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2024-06-20 Feature Articles  Explore Spending Estimates and Public Health Burden by Disease Category NIAID often encourages researchers to use NIH RePORT tools—including Research, Condition, and Disease Categorization (RCDC)—to identify potential collaborators. Opportunities and Resources New Initiative Shines a Spotlight on Women's Health in HIV Research Continuum NIAID is interested in supporting research programs that focus on HIV and other health outcomes in women to inform and enable more targeted and effective HIV prevention and treatment. Apply to Develop Global Infectious Disease Research Training Programs This initiative aims to strengthen the research capacity of institutions in low- and middle-income countries to investigate methods for preventing, treating, and controlling infectious diseases that pose significant health risks. Call for Applications for the Lasker Clinical Research Scholars Program The Lasker Scholars program supports candidates in two phases: an initial phase within the NIH Intramural Research Program and a subsequent phase with extramural grant funding. Contribute to Rare Diseases Clinical Research Consortia Each consortium will advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research. In The News Revised Guidance for Reporting DMS Plan Activities in Progress Reports When you complete your next Research Performance Progress Report, you may encounter new questions that address the NIH Data Management and Sharing (DMS) Policy. Proposed Policy to Promote Patient Access to Products Based on NIH-Owned Inventions Provide feedback on a draft policy and accompanying draft license agreement language that incorporates patient access in the commercialization process for NIH-owned inventions. News Briefs and Worth Repeating Temporary Exemption of H5 Avian Influenza Viruses from Select Agents Regulations NIH Sets Expectations for Upholding the NIH-Lacks Family Agreement Answer Request for Information on All of Us Research Program Advice Corner For Ancillary Studies, Consider NIH Definitions Carefully An ancillary study is an independent research project that uses samples or data from a parent study to extend knowledge in scientific areas beyond the original scope of the parent study. It may qualify as a clinical study or a clinical trial. Reader Questions "I saw the NIAID Research Agenda for 2024 H5N1 Influenza and I want to apply for H5N1 research funding, but I can't find a corresponding notice of funding opportunity. What should I do?" "Are there parent notices of funding opportunity for cooperative agreements?" New Funding Opportunities RFA-AT-24-010, Whole Person Research and Coordination Center (U24, Clinical Trial Not Allowed) RFA-AI-24-029, Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01, Clinical Trial Not Allowed) NOT-OD-24-145, Notice of Special Interest: R13 Support for Conferences and Scientific Meetings to Support Consensus Building for Autoimmune Disease Research Related Common Data Elements RFA-ES-24-005, CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01, Clinical Trial Not Allowed) Find other announcements at NIAID Opportunities and Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period.  This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107